World News: 08:46 GMT Friday 14th September 2018. [Zealand Pharma A/S via Globe Newswire via SPi World News]
The exercise price was DKK 101.20 per share and the total proceeds to Zealand from the capital increase amount to DKK 759,000.00.
The new shares give rights to dividend and other rights from the time of the warrant holder's exercise notice. Each new share carries one vote at Zealand's general meetings. Zealand has only one class of shares.
The new shares will be listed on Nasdaq Copenhagen after registration of the capital increase with the Danish Business Authority. Following registration of the new shares, the share capital of Zealand will be nominal DKK 30,758,827 divided into 30,758,827 shares with a nominal value of DKK 1 each.
The amendment to Zealand's Articles of Association entailed by the share capital increase has today been registered with the Danish Business Authority.
Britt Meelby Jensen, President and Chief Executive Officer Tel.: +45 51 67 61 28, e-mail:
Mats Blom, Executive Vice President and Chief Financial Officer Tel.: +45 31 53 79 73, e-mail:
Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.
Globe Newswire: 08:46 GMT Friday 14th September 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.